GPT and metabolic dysfunction-associated steatohepatitis: Currently available serum biomarkers for noninvasively differentiating simple steatosis from NASH such as alanine aminotransferase (ALT)‐levels and cytokeratin‐18 fragments are suboptimal, exhibiting poor reproducibility and low accuracy.38